AR004052A1 - Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico - Google Patents
Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergicoInfo
- Publication number
- AR004052A1 AR004052A1 ARP960104829A ARP960104829A AR004052A1 AR 004052 A1 AR004052 A1 AR 004052A1 AR P960104829 A ARP960104829 A AR P960104829A AR P960104829 A ARP960104829 A AR P960104829A AR 004052 A1 AR004052 A1 AR 004052A1
- Authority
- AR
- Argentina
- Prior art keywords
- cosmetic
- beta
- pharmaceutical composition
- adrenergic agonist
- composition including
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title abstract 5
- 239000000808 adrenergic beta-agonist Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 abstract 2
- 102100024304 Protachykinin-1 Human genes 0.000 abstract 2
- 101800003906 Substance P Proteins 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 230000004075 alteration Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000000622 irritating effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a la utilización de al menos un agonista beta-adrenérgico en una composición cosmética como antagonista de substancia Po para la preparación de una composición farmacéutica, más particularmente dermatológica,d estinada a tratar las alteraciones asociadas con un exceso desíntesis y/o de liberación de substancia P. La invención se refiere igualmente a una composición cosmética o farmacéutica, para uso tópico, que comprende almenos un agonistabeta-adrenérgi co y un procedimiento de tratamiento cosmético con miras a disminuir el dolor relacionado con un exceso de síntesis y/o deliberación de substancia P o disminuir el efecto irritante de una composición cosmética.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9512447A FR2740040B1 (fr) | 1995-10-23 | 1995-10-23 | Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR004052A1 true AR004052A1 (es) | 1998-09-30 |
Family
ID=9483809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960104829A AR004052A1 (es) | 1995-10-23 | 1996-10-21 | Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5958432A (es) |
| EP (1) | EP0769293B1 (es) |
| JP (1) | JP3636473B2 (es) |
| AR (1) | AR004052A1 (es) |
| BR (1) | BR9611302A (es) |
| CA (1) | CA2222311C (es) |
| DE (1) | DE69603681T2 (es) |
| DK (1) | DK0769293T3 (es) |
| FR (1) | FR2740040B1 (es) |
| HU (1) | HUP9900511A3 (es) |
| NO (1) | NO312273B1 (es) |
| PL (1) | PL186366B1 (es) |
| RU (1) | RU2169552C2 (es) |
| WO (1) | WO1997015281A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948972A (en) * | 1994-12-22 | 1999-09-07 | Kla-Tencor Corporation | Dual stage instrument for scanning a specimen |
| US20050043321A1 (en) * | 2000-07-26 | 2005-02-24 | Vyden John K. | Method for treating atopic disorders |
| ITPD20010187A1 (it) * | 2001-07-23 | 2003-01-23 | Cutech Srl | Trattamento del follicolo polifero, in particolare contro la caduta dei capelli |
| EP1295599A1 (en) * | 2001-09-21 | 2003-03-26 | Boehringer Ingelheim International GmbH | Method for the treatment of prevention of atopic dermatitis |
| US20030219573A1 (en) * | 2002-03-27 | 2003-11-27 | Torgny Falk | Absorbent product |
| US7345065B2 (en) * | 2002-05-21 | 2008-03-18 | Allergan, Inc. | Methods and compositions for alleviating pain |
| RU2220738C1 (ru) * | 2002-08-30 | 2004-01-10 | Гапонюк Петр Яковлевич | Средство для лечения ринита |
| US8343519B2 (en) * | 2003-02-19 | 2013-01-01 | L'oreal S.A. | Chemical enhancer and method |
| US20040209850A1 (en) * | 2003-04-15 | 2004-10-21 | Theraquest Biosciences, Llc | Methods of treating pain and compositions for use therefor |
| WO2006054513A1 (ja) * | 2004-11-19 | 2006-05-26 | Kissei Pharmaceutical Co., Ltd. | 神経因性疼痛の予防又は治療剤 |
| DK1719507T3 (da) * | 2005-04-13 | 2010-11-01 | Astion Dev As | Beta-2 adrenoceptoragonister til behandling af bindevævsygdomme i huden |
| ATE530174T1 (de) * | 2008-01-18 | 2011-11-15 | Centre Nat Rech Scient | Beta-2 adrenergische agonisten zur behandlung von chronischer neuropatischer allodynie |
| GB0805535D0 (en) * | 2008-03-27 | 2008-04-30 | Univ Leicester | Scar prevention |
| US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
| MA33059B1 (fr) * | 2009-02-24 | 2012-02-01 | Novartis Ag | Utilisation d'antagonistes des recepteurs nk |
| GB2513297A (en) | 2013-03-08 | 2014-10-29 | Univ Leicester | Methods |
| EP3319607A4 (en) * | 2015-07-09 | 2019-04-03 | Galderma S.A. | METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY |
| WO2019230230A1 (ja) * | 2018-05-29 | 2019-12-05 | 株式会社ナノエッグ | アトピー性皮膚炎を治療または予防するための組成物 |
| JP2022534826A (ja) * | 2018-09-08 | 2022-08-04 | タン ウェン | 炎症性腸疾患及びその腸管外発現の処置のためのアドレナリン作動性β２受容体アゴニストのＲ－エナンチオマーの新たな使用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1474316A (en) * | 1975-02-12 | 1977-05-25 | Seperic | O-aminoalkyl oximes |
| US4038417A (en) * | 1975-06-19 | 1977-07-26 | Nelson Research & Development Company | Method for treatment of psoriasis |
| US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
| US5366731A (en) * | 1990-08-24 | 1994-11-22 | Wisconsin Alumni Research Foundation | Cosmetic compositions containing secosterol compounds |
| IL99368A (en) * | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
| CA2114968A1 (en) * | 1993-02-25 | 1994-08-26 | John Wille | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
| JPH07258067A (ja) * | 1994-03-18 | 1995-10-09 | Kao Corp | 浴用剤組成物 |
| FR2719474B1 (fr) * | 1994-05-05 | 1996-05-31 | Oreal | Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue. |
-
1995
- 1995-10-23 FR FR9512447A patent/FR2740040B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-01 EP EP96402098A patent/EP0769293B1/fr not_active Expired - Lifetime
- 1996-10-01 HU HU9900511A patent/HUP9900511A3/hu unknown
- 1996-10-01 DE DE69603681T patent/DE69603681T2/de not_active Expired - Fee Related
- 1996-10-01 WO PCT/FR1996/001530 patent/WO1997015281A1/fr not_active Ceased
- 1996-10-01 DK DK96402098T patent/DK0769293T3/da active
- 1996-10-01 JP JP51633197A patent/JP3636473B2/ja not_active Expired - Fee Related
- 1996-10-01 PL PL96324924A patent/PL186366B1/pl not_active IP Right Cessation
- 1996-10-01 CA CA002222311A patent/CA2222311C/fr not_active Expired - Fee Related
- 1996-10-01 BR BR9611302A patent/BR9611302A/pt not_active IP Right Cessation
- 1996-10-01 RU RU97121883/14A patent/RU2169552C2/ru not_active IP Right Cessation
- 1996-10-21 AR ARP960104829A patent/AR004052A1/es not_active Application Discontinuation
- 1996-10-23 US US08/731,967 patent/US5958432A/en not_active Expired - Fee Related
-
1997
- 1997-12-30 NO NO19976143A patent/NO312273B1/no unknown
-
1999
- 1999-05-12 US US09/310,099 patent/US6267972B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR9611302A (pt) | 1999-03-30 |
| EP0769293B1 (fr) | 1999-08-11 |
| EP0769293A2 (fr) | 1997-04-23 |
| HUP9900511A3 (en) | 2000-09-28 |
| RU2169552C2 (ru) | 2001-06-27 |
| NO312273B1 (no) | 2002-04-22 |
| NO976143D0 (no) | 1997-12-30 |
| US6267972B1 (en) | 2001-07-31 |
| MX9710475A (es) | 1998-08-30 |
| FR2740040B1 (fr) | 1997-12-05 |
| JP3636473B2 (ja) | 2005-04-06 |
| EP0769293A3 (fr) | 1997-05-02 |
| CA2222311C (fr) | 2006-11-28 |
| DE69603681T2 (de) | 1999-11-25 |
| DE69603681D1 (de) | 1999-09-16 |
| CA2222311A1 (fr) | 1997-05-01 |
| NO976143L (no) | 1998-06-03 |
| US5958432A (en) | 1999-09-28 |
| JP2000503628A (ja) | 2000-03-28 |
| DK0769293T3 (da) | 1999-12-06 |
| PL324924A1 (en) | 1998-06-22 |
| WO1997015281A1 (fr) | 1997-05-01 |
| PL186366B1 (pl) | 2003-12-31 |
| FR2740040A1 (fr) | 1997-04-25 |
| HUP9900511A2 (hu) | 1999-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR004052A1 (es) | Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico | |
| ES2159382T3 (es) | Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones. | |
| MXPA02007822A (es) | Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa. | |
| ES2063073T3 (es) | Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios. | |
| MX9801596A (es) | Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas. | |
| ES2194935T3 (es) | Preparados estables de transglutaminasa y procedimiento para su preparacion. | |
| ES2120274T3 (es) | Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion. | |
| ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
| ES2081110T3 (es) | Composicion cosmetica o farmaceutica, particularmente dermatologica, destinada a favorecer la pigmentacion de la piel o de los cabellos, que contiene un extracto de cyperus y su procedimiento de fabricacion. | |
| MX9301929A (es) | Derivados de pirimidina y procedimientos para su preparacion. | |
| ATE288744T1 (de) | Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut | |
| ES2176795T3 (es) | Composiciones a base de esfingomielanasa y su utilizacion. | |
| ES2145143T3 (es) | Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel. | |
| ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
| AR006405A1 (es) | Utilizacion de un extracto de al menos un iridacea en el tratamiento de las arrugas. | |
| AR017222A1 (es) | Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos | |
| ATE259210T1 (de) | Trichologische lotion für die topische anwendung | |
| HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
| RU95103892A (ru) | Композиция топического нанесения для стимулирования роста волос и/или замедления их выпадения, способ косметического лечения волос, применение производного альфа -пирона для получения композиции | |
| UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
| TR199802769T2 (xx) | Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim. | |
| PT817625E (pt) | Composicoes para o tratamento de pele fotodanificada, compreendendo um antagonista de rar-alfa e um retinoide multi-selectivo | |
| BR9814937A (pt) | Utilização de uma quantidade suficiente de pelo menos um extrato de pelo um vegetal do gênero chrysanthemum, composição cosmética ou farmacêutica e processo de tratamento cosmético. | |
| ATE237331T1 (de) | Deuterierte wirkstoffe in transdermaler applikation | |
| AR004326A1 (es) | Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |